Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Oncology

PDF

2004

Institution
Keyword
Publication
Publication Type

Articles 1 - 29 of 29

Full-Text Articles in Medicine and Health Sciences

Expression Of Inwardly Rectifying Potassium Channels (Girks) And Beta-Adrenergic Regulation Of Breast Cancer Cell Lines, Howard K. Plummer, Qiang Yu, Yavuz Cakir, Hildegard M. Schuller Dec 2004

Expression Of Inwardly Rectifying Potassium Channels (Girks) And Beta-Adrenergic Regulation Of Breast Cancer Cell Lines, Howard K. Plummer, Qiang Yu, Yavuz Cakir, Hildegard M. Schuller

Faculty Publications and Other Works -- General Biology

Background

Previous research has indicated that at various organ sites there is a subset of adenocarcinomas that is regulated by beta-adrenergic and arachidonic acid-mediated signal transduction pathways. We wished to determine if this regulation exists in breast adenocarcinomas. Expression of mRNA that encodes a G-protein coupled inwardly rectifying potassium channel (GIRK1) has been shown in tissue samples from approximately 40% of primary human breast cancers. Previously, GIRK channels have been associated with beta-adrenergic signaling.

Methods

Breast cancer cell lines were screened for GIRK channels by RT-PCR. Cell cultures of breast cancer cells were treated with beta-adrenergic agonists and antagonists, and …


Orbital Embryonal Rhabdomyosarcomain Karachi (1998-2002), Yasmin Bhurgri, A. Mazhar, H. Bhurgri, A. Usman, J. Malik, A. Bhurgri, R. Ahmed, S. Muzaffar, N. Kayani, Shahid Pervez, S. H. Hasan Nov 2004

Orbital Embryonal Rhabdomyosarcomain Karachi (1998-2002), Yasmin Bhurgri, A. Mazhar, H. Bhurgri, A. Usman, J. Malik, A. Bhurgri, R. Ahmed, S. Muzaffar, N. Kayani, Shahid Pervez, S. H. Hasan

Department of Pathology and Laboratory Medicine

Objective: To study the epidemiology of ocular Rhabdomyosarcoma (ORMS) in Karachi.

Methods: Incident ORMS cases resident of Karachi, registered at Karachi Cancer Registry (KCR) during 1st January 1998 to 31st December 2002 were included in the study. The data were classified using ICD-O2; computerized with Canreg-3, and analyzed using SPSS 10.0.

Results: Ten cases of ORMS were reported to KCR during 1998-2002. RMS originated in the orbit in eight cases, conjunctiva in one and eyelid in one. Nine cases presented with proptosis, associated with conjunctivitis in four cases. One case presented with eyelid swelling. The crude annual incidence rate was …


Distinct Gene Expression Profiles In Different B-Cell Compartments In Human Peripheral Lymphoid Organs., Yulei Shen, Javeed Iqbal, Li Xiao, Ryan C. Lynch, Andreas Rosenwald, Louis M. Staudt, Simon Sherman, Karen Dybkaer, Guimei Zhou, James D. Eudy, Jan Delabie, Timothy W. Mckeithan, Wing C. Chan Sep 2004

Distinct Gene Expression Profiles In Different B-Cell Compartments In Human Peripheral Lymphoid Organs., Yulei Shen, Javeed Iqbal, Li Xiao, Ryan C. Lynch, Andreas Rosenwald, Louis M. Staudt, Simon Sherman, Karen Dybkaer, Guimei Zhou, James D. Eudy, Jan Delabie, Timothy W. Mckeithan, Wing C. Chan

Journal Articles: Eppley Institute

BACKGROUND: There are three major B-cell compartments in peripheral lymphoid organs: the germinal center (GC), the mantle zone (MNZ) and the marginal zone (MGZ). Unique sets of B-cells reside in these compartments, and they have specific functional roles in humoral immune response. MNZ B cells are naive cells in a quiescent state and may participate in GC reactions upon proper stimulation. The adult splenic MGZ contains mostly memory B cells and is also known to provide a rapid response to particulate antigens. The GC B-cells proliferate rapidly and undergo selection and affinity maturation. The B-cell maturational process is accompanied by …


Oncolog, Volume 49, Number 12, December 2004, David Galloway, Katie Prout Matias, Diane Witter, Paul Mathew Md Sep 2004

Oncolog, Volume 49, Number 12, December 2004, David Galloway, Katie Prout Matias, Diane Witter, Paul Mathew Md

OncoLog MD Anderson's Report to Physicians (All issues)

  • Advances in Prostate Cancer Treatment
  • Everyday Drugs Show New Promise for Cancer
  • Are COX-2 Inhibitors Safe?
  • House Call: Myths & Facts about Cancer Prevention
  • DiaLog: Neoadjuvant Trials in Prostate Cancer, by Paul Mathew, MD, Assistant Professor, Department of Genitourinary Medical Oncology


Oncolog, Volume 49, Number 11, November 2004, Rachel Williams, Steve C. Stuyck Mph Sep 2004

Oncolog, Volume 49, Number 11, November 2004, Rachel Williams, Steve C. Stuyck Mph

OncoLog MD Anderson's Report to Physicians (All issues)

  • The Youngest Cancer Patients
  • Meeting the Rising Demand for Outpatient Care
  • House Call: Going Beyond the Headlines: Tips to help you evaluate cancer stories in the news media
  • DiaLog: Cancer Information in the Media, by Stephen C. Stuyck, MPH, Vice President for Public Affairs


Oncolog, Volume 49, Number 10, October 2004, Dawn Chalaire, Sunni Hosemann, David Galloway, Karen Basen-Engquist Phd, Mph Sep 2004

Oncolog, Volume 49, Number 10, October 2004, Dawn Chalaire, Sunni Hosemann, David Galloway, Karen Basen-Engquist Phd, Mph

OncoLog MD Anderson's Report to Physicians (All issues)

  • Treating Head and Neck Cancer Requires Extraordinary Coordination Among Disciplines
  • Researchers Seek to Understand the Mysteries of Uterine Cancer and to Find Better Treatments
  • Mammography vs. Magnetic Resonance Imaging: A Breast Cancer Prevention Specialist and a Radiologist Weigh in on the Recent Debate
  • House Call: The Role of Alcohol and Tobacco in Head and Neck Cancer
  • DiaLog: Sexuality after Gynecologic Cancer, by Karen Basen-Engquist, PhD, Associate Professor, Department of Behavioral Health


Oncolog, Volume 49, Number 09, September 2004, Ellen Mcdonald, Ann Sutton, David Galloway, Rena Sellin Md Sep 2004

Oncolog, Volume 49, Number 09, September 2004, Ellen Mcdonald, Ann Sutton, David Galloway, Rena Sellin Md

OncoLog MD Anderson's Report to Physicians (All issues)

  • New Approaches to Managing Tumors of the Pituitary Gland Offer Patients Hope
  • Needleless Chemotherapy: Safety and Efficacy of Aerosolized Chemotherapy Being Studied in Young Patients with Cancer
  • M. D. Anderson Physician Honored for Inventing an Antimicrobial Catheter That Prevents 25,000 Infection-Related Deaths a Year
  • House Call: How Cancer Happens and Ways to Lower Your Risk
  • DiaLog: Cancer-Related Neuroendocrine Dysfunction, by Rena V. Sellin, MD, Professor, Department of Endocrine Neoplasia and Hormonal Disorders


Gitr Activation Induces An Opposite Effect On Alloreactive Cd4(+) And Cd8(+) T Cells In Graft-Versus-Host Disease., Stephanie J Muriglan, Teresa Ramirez-Montagut, Onder Alpdogan, Thomas W Van Huystee, Jeffrey M Eng, Vanessa M Hubbard, Adam A Kochman, Kartono H Tjoe, Carlo Riccardi, Pier Paolo Pandolfi, Shimon Sakaguchi, Alan N Houghton, Marcel R M Van Den Brink Jul 2004

Gitr Activation Induces An Opposite Effect On Alloreactive Cd4(+) And Cd8(+) T Cells In Graft-Versus-Host Disease., Stephanie J Muriglan, Teresa Ramirez-Montagut, Onder Alpdogan, Thomas W Van Huystee, Jeffrey M Eng, Vanessa M Hubbard, Adam A Kochman, Kartono H Tjoe, Carlo Riccardi, Pier Paolo Pandolfi, Shimon Sakaguchi, Alan N Houghton, Marcel R M Van Den Brink

Department of Medical Oncology Faculty Papers

Glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR) is a member of the tumor necrosis factor receptor (TNFR) family that is expressed at low levels on unstimulated T cells, B cells, and macrophages. Upon activation, CD4(+) and CD8(+) T cells up-regulate GITR expression, whereas immunoregulatory T cells constitutively express high levels of GITR. Here, we show that GITR may regulate alloreactive responses during graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation (BMT). Using a BMT model with major histocompatibility complex class I and class II disparity, we demonstrate that GITR stimulation in vitro and in vivo enhances alloreactive CD8(+)CD25(-) T …


Cancer Esophagus Karachi 1995-2002:Epidemiology, Risk Factors And Trends, Y. Bhurgri, N. Faridi, L. A.G. Kazi, S. K. Ali, H. Bhurgri, A. Usman, J. Malik, A. Bhurgri, R. Ahmed, S. Muzaffar, N. Kayani, Shahid Pervez, S. H. Hasan Jul 2004

Cancer Esophagus Karachi 1995-2002:Epidemiology, Risk Factors And Trends, Y. Bhurgri, N. Faridi, L. A.G. Kazi, S. K. Ali, H. Bhurgri, A. Usman, J. Malik, A. Bhurgri, R. Ahmed, S. Muzaffar, N. Kayani, Shahid Pervez, S. H. Hasan

Department of Pathology and Laboratory Medicine

Objective: To study the trends of cancer esophagus in Karachi South during 1995-2002 and identify risk factors.

Methods: Incident esophageal cancer cases recorded at the Karachi Cancer Registry for Karachi South, during 1st January 1995 to 31st December 2003 were reviewed. For maximum completion of data, incident cases registered from 1st January 1995 to 31st December 2002 were included for final analyses.

Results: The Age Standardized Incidence Rates (ASIRs) of cancer esophagus in Karachi South for males were 6.5/100,000 (1995-1997) and 6.4/100,000 (1998-2002). In females the observed rates were 7.0/100,000 (1995-1997) and 8.6/100,000 (1998-2002).

Conclusion: In the moderately high incidence, …


Oncolog, Volume 49, Number 07/08, July/August 2004, Dawn Chalaire, David Galloway, Ellen Manzullo Md Jul 2004

Oncolog, Volume 49, Number 07/08, July/August 2004, Dawn Chalaire, David Galloway, Ellen Manzullo Md

OncoLog MD Anderson's Report to Physicians (All issues)

  • Proton Therapy Comes into Its Own
  • Treating Patients with Cancer Requires Looking Beyond the Tumor
  • House Call: Protecting Yourself Against Skin Cancer
  • DiaLog: Treating Cancer-Related Fatigue, by Ellen Manzullo, MD, FACP, Department of General Internal Medicine, Ambulatory Treatment, and Emergency Care


Oncolog, Volume 49, Number 06, June 2004, Kate O'Suilleabhain, Katie Prout Matias, Jack Roth Md Jun 2004

Oncolog, Volume 49, Number 06, June 2004, Kate O'Suilleabhain, Katie Prout Matias, Jack Roth Md

OncoLog MD Anderson's Report to Physicians (All issues)

  • Despite Initial Setbacks, Researchers Are Focusing on Antiangiogenic Therapy More Than Ever
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging Predicts Response to Antiangiogenesis Agents
  • "Smart Bombs": Targeted Therapies Home in on Increasingly Well-Defined Targets
  • House Call: Understanding Angiogenesis
  • DiaLog: Gene Therapy for Cancer: Safety First, by Jack Roth, MD, Chair, Department of Thoracic and Cardiovascular Surgery


The Anti-Proliferation Effects Of Lycopene On Breast Cancer Cells, Tixieanna Dissmore Jun 2004

The Anti-Proliferation Effects Of Lycopene On Breast Cancer Cells, Tixieanna Dissmore

Loma Linda University Electronic Theses, Dissertations & Projects

Background: The incidence and deaths from breast cancer represent the most cause of all cancer deaths among women. Lycopene, the carotenoid in tomatoes has been associated with decreasing risk of prostate, breast, and digestive tract cancers. Various mechanisms of lycopene action have been proposed, including antioxidant activity and pro-differentiation activities. Identifying changes in the expression of proteins modified by lycopene can provide information to study the modulating effects of lycopene carcinogenesis and tumorigenesis development.

Objective: The objective was to study the anti-proliferative effects of lycopene on MCF- 7 human breast cancer cells and to identify changes in protein expression patterns. …


Oncolog, Volume 49, Number 05, May 2004, David Galloway, Dawn Chalaire, Emil J. Freireich Md May 2004

Oncolog, Volume 49, Number 05, May 2004, David Galloway, Dawn Chalaire, Emil J. Freireich Md

OncoLog MD Anderson's Report to Physicians (All issues)

  • Experts Recommend Treating Cancer Pain in the Context of Other Symptoms
  • Protocols: Studies Examine Treatment for Cancer-Related Pain
  • Participation of Elderly Patients in Clinical Trials: Looking Beyond Age
  • House Call: From Cancer Research to Clinical Practice
  • DiaLog: The Next 20 Years: The Changing Face of Cancer Treatment, by Emil J. Freireich, MD, Director, Adult Leukemia Research Program


Oncolog, Volume 49, Number 04, April 2004, Katie Prout Matias, Karen Stuyck Apr 2004

Oncolog, Volume 49, Number 04, April 2004, Katie Prout Matias, Karen Stuyck

OncoLog MD Anderson's Report to Physicians (All issues)

  • Gastric Cancer Studies Focus on Prolonging Survival and Finding Molecular Markers for Targeted Therapies
  • Clinical Ethicists Help Patients, Families, and Staff Resolve Difficult Dilemmas
  • An Unexpected Finding: Male Breast Cancer Is Rare and Often Overlooked
  • House Call: Getting Screened for Oral Cancer


Molecular Dynamics Simulations Of The O-Glycosylated 21-Residue Muc1 Peptides, A. Rubinstein, L. Kinarsky, S. Sherman Mar 2004

Molecular Dynamics Simulations Of The O-Glycosylated 21-Residue Muc1 Peptides, A. Rubinstein, L. Kinarsky, S. Sherman

Journal Articles: Eppley Institute

The conformational propensities of the 21-residue peptide and its Oglycosylated analogs were studied by molecular dynamics (MD) simulations. This polypeptide motif comprises the tandem repeat of the human mucin (MUC1) protein core that is differently glycosylated in normal and cancer cells. To evaluate the structural effects of O-glycosylation on the polypeptide backbone, conformations of the nonglycosylated peptide and its glycosylated analogs were monitored during the 1 ns MD simulations. Radius gyration for whole peptide and its fragments, as well as root-mean-square-deviation between coordinate sets of the backbone atoms of starting structures and generated structures, were calculated. It was shown that …


Oncolog, Volume 49, Number 03, March 2004, Beth Notzon, Katie Prout Matias Mar 2004

Oncolog, Volume 49, Number 03, March 2004, Beth Notzon, Katie Prout Matias

OncoLog MD Anderson's Report to Physicians (All issues)

  • Translational Research Speeds the Journey from Lab Results to Clinical Outcomes
  • New Tests Could One Day Predict Response to Chemotherapy and Presence of Metastatic Disease in Patients with Breast Cancer
  • House Call: Mind-Body Approaches for Patients with Cancer


All-1/Mll1, A Homologue Of Drosophila Trithorax, Modifies Chromatin And Is Directly Involved In Infant Acute Leukaemia., E Canaani, T Nakamura, T Rozovskaia, S T Smith, T Mori, C M Croce, Alexander Mazo Feb 2004

All-1/Mll1, A Homologue Of Drosophila Trithorax, Modifies Chromatin And Is Directly Involved In Infant Acute Leukaemia., E Canaani, T Nakamura, T Rozovskaia, S T Smith, T Mori, C M Croce, Alexander Mazo

Kimmel Cancer Center Faculty Papers

Rearrangements of the ALL-1/MLL1 gene underlie the majority of infant acute leukaemias, as well as of therapy-related leukaemias developing in cancer patients treated with inhibitors of topoisomerase II, such as VP16 and doxorubicin. The rearrangements fuse ALL-1 to any of >50 partner genes or to itself. Here, we describe the unique features of ALL-1-associated leukaemias, and recent progress in understanding molecular mechanisms involved in the activity of the ALL-1 protein and of its Drosophila homologue TRITHORAX.


Nmr-Based Structural Studies Of The Glycosylated Muc1 Tandem Repeat Peptide, G. Suryanarayanan, P. A. Keifer, G. Wang, L. Kinarsky, M. A. Hollingsworth, S. Sherman Feb 2004

Nmr-Based Structural Studies Of The Glycosylated Muc1 Tandem Repeat Peptide, G. Suryanarayanan, P. A. Keifer, G. Wang, L. Kinarsky, M. A. Hollingsworth, S. Sherman

Journal Articles: Eppley Institute

MUC1 is a glycoprotein that plays an important role in cancer pathogenesis. In order to study the effect of glycosylation on the conformational propensities of the tandem repeat domain of MUC1, we have determined the structure of the MUC1 tandem repeat peptide AHGVTSAPDTRPAPGSTAPP, O-glycosylated with the trisaccharide (α-Glc-1,4-β-Glc-1,4-α-GalNAc-) at Thr5. This glycopeptide was synthesized to model a heavily Oglycosylated threonine residue in the tandem repeat domain. The NMR experiments used in this study included TOCSY, NOESY, ROESY, DQF-COSY, HSQC and 1D NMR. The peak volumes determined using the program SPARKY were converted into distance constraints using the program CALIBA. The …


Oncolog, Volume 49, Number 02, February 2004, Sunni Hosemann, Aurelio Matamoros Feb 2004

Oncolog, Volume 49, Number 02, February 2004, Sunni Hosemann, Aurelio Matamoros

OncoLog MD Anderson's Report to Physicians (All issues)

  • Colorectal Cancer Screening: Encouraging Compliance Today and Looking to the Future
  • Despite Its Drawbacks, Mammography Is Still Recommended
  • Communication Is Essential When Guiding Patients through the Maze of Genetic Breast Cancer Screening
  • House Call: Cancer Epidemiology, Step-by-Step
  • DiaLog: On Being a Volunteer, by Anderson Network volunteer


Albumin Enhanced Morphometric Image Analysis In Cll., Matthew A. Lunning, Vincent E. Zenger, Ricardo Dreyfuss, Maryalice Stetler-Stevenson, Margaret E. Rick, Therese A. White, Wyndham H. Wilson, Gerald E. Marti Jan 2004

Albumin Enhanced Morphometric Image Analysis In Cll., Matthew A. Lunning, Vincent E. Zenger, Ricardo Dreyfuss, Maryalice Stetler-Stevenson, Margaret E. Rick, Therese A. White, Wyndham H. Wilson, Gerald E. Marti

Journal Articles: Oncology and Hematology

BACKGROUND: The heterogeneity of lymphocytes from patients with chronic lymphocytic leukemia (CLL) and blood film artifacts make morphologic subclassification of this disease difficult.

METHODS: We reviewed paired blood films prepared from ethylene-diamine-tetraacetic acid (ETDA) samples with and without bovine serum albumin (BSA) from 82 CLL patients. Group 1 adhered to NCCLS specifications for the preparations of EDTA blood films. Group 2 consisted of blood films containing EDTA and a 1:12 dilution of 22% BSA. Eight patients were selected for digital photomicroscopy and statistical analysis. Approximately 100 lymphocytes from each slide were digitally captured.

RESULTS: The mean cell area +/- standard …


Imaging Genome Abnormalities In Cancer Research, Henry Hq Heng, Joshua B. Stevens, Guo Liu, Steven W. Bremer, Christine J. Ye Jan 2004

Imaging Genome Abnormalities In Cancer Research, Henry Hq Heng, Joshua B. Stevens, Guo Liu, Steven W. Bremer, Christine J. Ye

Wayne State University Associated BioMed Central Scholarship

Abstract

Increasing attention is focusing on chromosomal and genome structure in cancer research due to the fact that genomic instability plays a principal role in cancer initiation, progression and response to chemotherapeutic agents. The integrity of the genome (including structural, behavioral and functional aspects) of normal and cancer cells can be monitored with direct visualization by using a variety of cutting edge molecular cytogenetic technologies that are now available in the field of cancer research. Examples are presented in this review by grouping these methodologies into four categories visualizing different yet closely related major levels of genome structures. An integrated …


2003 Cancer Care Annual Report, Children's Mercy Hospital Jan 2004

2003 Cancer Care Annual Report, Children's Mercy Hospital

Cancer Center Annual Reports

Annual report of cancer care and oncology services at the Children's Mercy Hospital, Kansas City MO, a pediatric medical center, with a focus on AML.


Increased Risk For Aplastic Anemia And Myelodysplastic Syndrome In Individuals Lacking Glutathione S-Transferase Genes, Joanne F. Sutton, Michael Stacey, William G. Kearns, Thomas S. Roeg, Neal S. Young, Johnson M. Liu Jan 2004

Increased Risk For Aplastic Anemia And Myelodysplastic Syndrome In Individuals Lacking Glutathione S-Transferase Genes, Joanne F. Sutton, Michael Stacey, William G. Kearns, Thomas S. Roeg, Neal S. Young, Johnson M. Liu

Bioelectrics Publications

BACKGROUND: Aplastic anemia (AA) and myelodysplastic syndrome (MDS) are marrow failure states that may be associated with chromosomal instability. An absence of the glutathione S-transferase (GST) enzyme may genetically predispose individuals to AA or MDS. PROCEDURE AND RESULTS: To test this hypothesis, we determined the GSTM1 and GSTT1 genotypes in a total of 196 patients using multiplex PCR. The GSTT1 null genotype was found to be overrepresented in Caucasian, Asian, and Hispanic patients with either AA or MDS. We confirmed a difference in the expected frequency of the GSTM1 null genotype in Caucasian MDS patients. The double null GSTM1/GSTT1 …


Expression Of Ps2 In Prostate Cancer Correlates With Grade And Chromogranin A Expression But Not With Stage, Hammad Ather, Farhat Abbas, Nuzhat Faruqui, M Israr, Shahid Pervez Jan 2004

Expression Of Ps2 In Prostate Cancer Correlates With Grade And Chromogranin A Expression But Not With Stage, Hammad Ather, Farhat Abbas, Nuzhat Faruqui, M Israr, Shahid Pervez

Department of Pathology and Laboratory Medicine

Background: The biological potential of prostate cancer is extremely variable. Particular interest is focused on markers not expressed in normal prostatic tissues. pS2 protein expression has been demonstrated in a range of malignant tissues in an oestrogen-independent pathway. Recently, it has been demonstrated that pS2, in prostate cancer, is closely associated with neuro-endocrine differentiation. In the present study, we have analyzed, the potential of Neuro-endocrine and pS2 (TFF1) expression in human prostate cancer determined by immunohistochemistry, in primary adenocarcinoma of the prostate and attempted to correlate this with the clinico-pathologic features of the patient and neuroendocrine expression.

Methods: Ninety-five malignant …


The Therapeutic Effects Of Exercise On Fatigue, Davina Porock, Mei Fu Jan 2004

The Therapeutic Effects Of Exercise On Fatigue, Davina Porock, Mei Fu

Publications and Research

No abstract provided.


Pulmonary Infiltrates During Chemotherapy-Induced Febrile Neutropenia: Incidence, Patterns And Outcomes, N. Gangat, M.A.A. Khan, M. Mujib, Mohammad Khurshid Jan 2004

Pulmonary Infiltrates During Chemotherapy-Induced Febrile Neutropenia: Incidence, Patterns And Outcomes, N. Gangat, M.A.A. Khan, M. Mujib, Mohammad Khurshid

Section of Haematology/Oncology

OBJECTIVE: To analyze the incidence, etiologies, radiographic patterns, and clinical outcomes of adult leukemics with prolonged febrile neutropenia and pneumonia.
METHODS: A retrospective study was conducted at a tertiary care hospital. The medical records of adult patients with acute myeloid leukemia diagnosed between January 1989 and June 2000 and undergoing induction chemotherapy were included. Only the patients who presented with a pulmonary infiltrate, secondary leukemia (e.g., transformed chronic myeloid leukemia underlying myelodysplastic syndrome, or disease following alkylating agent therapy) were included and those developing infiltrates following consolidation chemotherapy were excluded.
RESULTS: A total of 124 patients were admitted …


Oncolog, Volume 49, Number 01, January 2004, David Galloway, Katie Prout Matias, Karin M.E.H. Gwyn Md, Richard L. Theriault Do Jan 2004

Oncolog, Volume 49, Number 01, January 2004, David Galloway, Katie Prout Matias, Karin M.E.H. Gwyn Md, Richard L. Theriault Do

OncoLog MD Anderson's Report to Physicians (All issues)

  • Pregnancy and Cancer Treatment Often Are Not Mutually Exclusive
  • Studies of the Viral Origins of Some Cancers Lead to New Prevention, Treatment Strategies
  • House Call: Cancer and Your Weight
  • DiaLog: Treating Breast Cancer during Pregnancy, by Karin M.E.H. Gwyn, MD, Assistant Professor, and Richard L. Theriault, DO, Professor, Department of Breast Medical Oncology


Lung Cancer Trends. Part 1: North America, P. Tai, E. Yu Dec 2003

Lung Cancer Trends. Part 1: North America, P. Tai, E. Yu

Edward Yu

No abstract provided.


Malignant Pleural Mesothelioma: World Trends, P. Tai, E. Yu Dec 2003

Malignant Pleural Mesothelioma: World Trends, P. Tai, E. Yu

Edward Yu

No abstract provided.